Celanese Corporation has inaugurated its expanded Michigan Technology Center while grappling with substantial financial hurdles, including a 24.62% miss on fourth-quarter earnings estimates and a 7% revenue decline. The company attributes its challenges primarily to volume and price pressures in its Acetyl Chain segment, yet it is actively pursuing a $1 billion divestiture target by 2027 to bolster cash flow and stabilize its balance sheet. Despite these difficulties, Celanese's shares have surged 39.2% this year, providing a contrasting outlook against broader market declines.